Argen-X

Beleggen, aandelen kopen in België, informatie, koersen en analyses

Gebruikersavatar
piddybull
Premiummember
Premiummember
Berichten: 3982
Lid geworden op: 21 jan 2013 22:45
Locatie: Aardbol afslag W.VL
waarderingen: 7368
Contacteer:

Re: Argen-X

Bericht door piddybull »

Breda, the Netherlands / Ghent, Belgium

argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, today announced that it will host a conference call and audio webcast on Thursday, October 22, 2020 at 2:30 p.m. CET (8:30 a.m. ET) to discuss its third quarter 2020 financial results and provide a business update.

A webcast of the live call may be accessed on the Investors section of the argenx website at argenx.com/investors. A replay of the webcast will be available on the argenx website for approximately one year following the call.

Dial-in numbers:

Please dial in 15 minutes prior to the live call.

Belgium 0800 389 13
France 0805 102 319
Netherlands 0800 949 4506
United Kingdom 0800 279 9489
United States 1 866 270 1533
International 1 412 317 0797


About argenx

argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx is evaluating efgartigimod in multiple serious autoimmune diseases, and cusatuzumab in hematological cancers in collaboration with Janssen. argenx is also advancing several earlier stage experimental medicines within its therapeutic franchises. argenx has offices in Belgium, the United States, and Japan. For more information, visit www.argenx.com and follow us on LinkedIn at https://www.linkedin.com/company/argenx/.

For further information, please contact:

Beth DelGiacco, Vice President, Investor Relations (US)
+1 518 424 4980
bdelgiacco@argenx.com

Joke Comijn, Director Corporate Communications & Investor Relations (EU)
+32 (0)477 77 29 44
+32 (0)9 310 34 19
jcomijn@argenx.com
Argenx

The Argonauts were able to achieve the unthinkable.







Volg Beursig.com op Twitter en Facebook


Gebruikersavatar
piddybull
Premiummember
Premiummember
Berichten: 3982
Lid geworden op: 21 jan 2013 22:45
Locatie: Aardbol afslag W.VL
waarderingen: 7368
Contacteer:

Re: Argen-X

Bericht door piddybull »

Shortpositie vermindering 0,59% (was 0,64 %) door CITADEL ADVISORS LLC.

Schermafbeelding 2020-10-16 om 15.56.30.png
Je hebt niet voldoende permissies om de bijlagen van dit bericht te bekijken.
Argenx

The Argonauts were able to achieve the unthinkable.

DVM_PhD
Forum actieveling
Forum actieveling
Berichten: 319
Lid geworden op: 21 nov 2017 10:16
waarderingen: 315
Contacteer:

Re: Argen-X

Bericht door DVM_PhD »

Ik mis de tijd dat het hier zo rustig was...

Gebruikersavatar
piddybull
Premiummember
Premiummember
Berichten: 3982
Lid geworden op: 21 jan 2013 22:45
Locatie: Aardbol afslag W.VL
waarderingen: 7368
Contacteer:

Re: Argen-X

Bericht door piddybull »

Niet teveel in het verleden gaan denken.
Argenx

The Argonauts were able to achieve the unthinkable.

Brotherhood
Forum actieveling
Forum actieveling
Berichten: 373
Lid geworden op: 07 mei 2014 21:01
waarderingen: 253
Contacteer:

Re: Argen-X

Bericht door Brotherhood »

DVM_PhD schreef:
16 okt 2020 16:22
Ik mis de tijd dat het hier zo rustig was...
Ja , want daarvoor dient een forum , om niets te posten of te delen ... :roll:


Deelnemen aan het forum + meer functies?

Deel kennis en vragen met duizenden beleggers,
minder advertenties, ideaal voor smartphone, betere
gebruikservaring en gratis abonneren op favoriete
onderwerpen. Registreer binnen 1 minuut!



Plaats reactie